These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
67 related articles for article (PubMed ID: 7349949)
1. Specific water-soluble binding sites for serum insulin-like peptides in human and animal tissues. Guyda HJ; Posner BI Endocrinology; 1980 Jan; 106(1):113-9. PubMed ID: 7349949 [No Abstract] [Full Text] [Related]
2. Preferential measurement of insulin-like growth factor (IGF) I-related peptides in serum with the aid of IGF-binding proteins (IGF BPs) produced by rat liver in culture. Estimation of serum IGF BP levels. Binoux M; Seurin D; Lassarre C; Gourmelen M J Clin Endocrinol Metab; 1984 Sep; 59(3):453-62. PubMed ID: 6205015 [TBL] [Abstract][Full Text] [Related]
3. Studies of insulin, growth hormone and prolactin binding: ontogenesis, effects of sex and pregnancy. Kelly PA; Posner BI; Tsushima T; Friesen HG Endocrinology; 1974 Aug; 95(2):532-9. PubMed ID: 4369224 [No Abstract] [Full Text] [Related]
4. Partial purification, characterization, and assay of a slightly acidic insulin-like peptide (ILAs) from human plasma. Posner BI; Guyda HJ; Corvol MT; Rappaport R; Harley C; Goldstein S J Clin Endocrinol Metab; 1978 Dec; 47(6):1240-50. PubMed ID: 400741 [TBL] [Abstract][Full Text] [Related]
5. Measurement of somatomedin-related peptides in fetal, neonatal, and maternal rat serum by insulin-like growth factor (IGF) I radioimmunoassay, IGF-II radioreceptor assay (RRA), and multiplication-stimulating activity RRA after acid-ethanol extraction. Daughaday WH; Parker KA; Borowsky S; Trivedi B; Kapadia M Endocrinology; 1982 Feb; 110(2):575-81. PubMed ID: 7035142 [TBL] [Abstract][Full Text] [Related]
6. Evidence that somatomedin-C is degraded by the kidney and inhibits insulin degradation. D'Ercole AJ; Decedue CJ; Furlanetto RW; Underwood LE; Van Wyk JJ Endocrinology; 1977 Aug; 101(2):577-86. PubMed ID: 885118 [No Abstract] [Full Text] [Related]
8. Ontogenic changes in multiplication-stimulating activity binding to tissues and serum somatomedin-like receptor activity in the ovine fetus. Owens PC; Brinsmead MW; Waters MJ; Thorburn GD Biochem Biophys Res Commun; 1980 Oct; 96(4):1812-20. PubMed ID: 6160856 [No Abstract] [Full Text] [Related]
9. Somatomedin-C receptor ontogeny and levels in porcine fetal and human cord serum. D'ercole AJ; Foushee DB; Underwood LE J Clin Endocrinol Metab; 1976 Nov; 43(5):1069-77. PubMed ID: 186474 [TBL] [Abstract][Full Text] [Related]
10. Studies of insulin, growth hormone and prolactin binding: tissue distribution, species variation and characterization. Posner BI; Kelly PA; Shiu RP; Friesen HG Endocrinology; 1974 Aug; 95(2):521-31. PubMed ID: 4369225 [No Abstract] [Full Text] [Related]
11. Serum somatomedin/insulin-like growth factor (IGF) and IGF carrier levels in patients with Cushing's syndrome or receiving glucocorticoid therapy. Gourmelen M; Girard F; Binoux M J Clin Endocrinol Metab; 1982 May; 54(5):885-92. PubMed ID: 7037821 [No Abstract] [Full Text] [Related]
12. Different insulin-like growth factor binding species in human placenta and decidua. Pekonen F; Suikkari AM; Mäkinen T; Rutanen EM J Clin Endocrinol Metab; 1988 Dec; 67(6):1250-7. PubMed ID: 2461387 [TBL] [Abstract][Full Text] [Related]
13. Effects of human growth hormone administration on serum somatomedins, somatomedin carrier proteins, and growth rates in children with growth hormone deficiency. Schalch DS; Tollefsen SE; Klingensmith GJ; Gotlin RW; Diehl MJ J Clin Endocrinol Metab; 1982 Jul; 55(1):49-55. PubMed ID: 6176592 [No Abstract] [Full Text] [Related]
14. Tissue-specific expression of insulin-like growth factor binding protein-3 protease activity during rat pregnancy. Davenport ML; Pucilowska J; Clemmons DR; Lundblad R; Spencer JA; Underwood LE Endocrinology; 1992 May; 130(5):2505-12. PubMed ID: 1374007 [TBL] [Abstract][Full Text] [Related]
15. Guinea pig serum contains a specific high affinity growth hormone-binding protein with novel ligand specificity. Ymer SI; Stevenson JL; Herington AC Endocrinology; 1997 Sep; 138(9):3577-86. PubMed ID: 9275038 [TBL] [Abstract][Full Text] [Related]
16. Hypoglycemia associated with non-islet-cell tumor and insulin-like growth factors. Froesch ER; Zapf J; Widmer U N Engl J Med; 1982 May; 306(19):1178-9. PubMed ID: 7040961 [No Abstract] [Full Text] [Related]
17. The insulin-like growth factors (IGF) of human serum: chemical and biological characterization and aspects of their possible physiological role. Zapf J; Froesch ER; Humbel RE Curr Top Cell Regul; 1981; 19():257-309. PubMed ID: 7037314 [No Abstract] [Full Text] [Related]
18. Measurement of insulin-like growth factor II by a specific radioreceptor assay in serum of normal individuals, patients with abnormal growth hormone secretion, and patients with tumor-associated hypoglycemia. Daughaday WH; Trivedi B; Kapadia M J Clin Endocrinol Metab; 1981 Aug; 53(2):289-94. PubMed ID: 7019228 [TBL] [Abstract][Full Text] [Related]
19. Enzymic N-acetylation of 2,4-toluenediamine by liver cytosols from various species. Glinsukon T; Benjamin T; Grantham PH; Weisburger EK; Roller PP Xenobiotica; 1975 Aug; 5(8):475-83. PubMed ID: 241157 [TBL] [Abstract][Full Text] [Related]
20. Role of the liver in regulating somatomedin activity: hormonal effects on the synthesis and release of insulin-like growth factor and its carrier protein by the isolated perfused rat liver. Schalch DS; Heinrich UE; Draznin B; Johnson CJ; Miller LL Endocrinology; 1979 Apr; 104(4):1143-51. PubMed ID: 436753 [No Abstract] [Full Text] [Related] [Next] [New Search]